AIM ImmunoTech Files 8-K on Shareholder Votes and Financials
Ticker: AIM · Form: 8-K · Filed: May 1, 2025 · CIK: 946644
Sentiment: neutral
Topics: corporate-governance, financials, filing
TL;DR
AIM ImmunoTech filed an 8-K on April 30, 2025, covering shareholder votes and financials.
AI Summary
AIM ImmunoTech Inc. filed an 8-K on May 1, 2025, reporting on matters submitted to a vote of security holders and financial statements as of April 30, 2025. The company, formerly known as Hemispherx Biopharma Inc., is incorporated in Delaware and operates in the biological products sector.
Why It Matters
This filing provides updates on corporate governance and financial status, which are crucial for investors to assess the company's operational health and strategic direction.
Risk Assessment
Risk Level: low — This is a routine filing reporting on standard corporate actions and financial statements, not indicating any immediate material changes or risks.
Key Players & Entities
- AIM ImmunoTech Inc. (company) — Registrant
- Hemispherx Biopharma Inc. (company) — Former company name
- April 30, 2025 (date) — Date of earliest event reported
- May 1, 2025 (date) — Filing date
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in this excerpt.
What is the primary business of AIM ImmunoTech Inc.?
AIM ImmunoTech Inc. operates in the Biological Products (no diagnostic substances) sector, SIC code 2836.
When was AIM ImmunoTech Inc. formerly known as?
AIM ImmunoTech Inc. was formerly known as HEMISPHERX BIOPHARMA INC.
What is the principal executive office address for AIM ImmunoTech Inc.?
The principal executive offices are located at 2117 SW Highway 484, Ocala, FL 34473.
What is the fiscal year end for AIM ImmunoTech Inc.?
The fiscal year end for AIM ImmunoTech Inc. is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 1, 2025 regarding AIM ImmunoTech Inc. (AIM).